Skip to content
★ Sign in to follow
모

모상현

Executive
바이오에프디엔씨바이오에프디엔씨
Total declarations
12
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 06 Oct 2026 for 바이오에프디엔씨.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

모상현: trading record in brief

This profile gathers the share dealings of 모상현 in 바이오에프디엔씨, where the filings describe the role as chief executive. Over a trading history stretching from 24 February 2022 to 6 October 2026, the count stands at 12 filings.

No open-market sale appears; the market trades are 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The latest filing, published on 6 October 2026, reports a transaction in 바이오에프디엔씨. The latest purchase dates back some time: it was published 563 days ago, on 24 April 2025. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Companies and markets linked to 모상현

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations